Brooks Laboratories Limited Share Price and Company Fundamentals
Last traded: Today at 7:05 AM
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections. It is also involved in loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries; and trading in pharmaceutical products, ingredients, and intermediaries. In addition, the company offers oncology products and hormonal injections; and formulations for therapeutic areas comprising antibiotic, pain management, controlled drugs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan, Nigeria, Lebanon, Mauritius, Sudan, Madagascar, the Democratic Republic of Congo, Angola, Mozambique, Latin America, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Key Metrics
PE ratio
14.92
PB ratio
1.57
Dividend yield
-
Beta
1.08
Market cap
₹1.93B
Enterprise value
₹1.94B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 347 |
| Website | https://www.brookslabs.net |
| Mailing address | 201, The Summit Business Park Behind Guru Nanak Petrol Pump Off. Andheri Kurla Road Andheri (East) Mumbai 400093 India |
| Phone / Fax | 91 22 6907 3100 / |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Brooks Laboratories Limited paid ₹- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BROOKS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on Brooks Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Prashant Rathi | CEO & CFO | 34 | |
| Ms. Krutika Mohan Rane | Company Secretary & Compliance Officer | 32 | |
| Dr. Durga Shankar Maity M.Sc. | Whole Time Director | 61 | |
| Mr. Rajesh Mahajan MBA | President of Trading | 56 | |
| Mr. Atul Ranchal PGDFMT | President of Corporate Strategy | 58 | |
| Mr. Jitendrapratap Rambahadur Singh | Whole Time Director | 52 | |
| Mr. Bhushan Singh Rana | Whole-Time Director | 70 | |
| Nikhil Anand Verma | Vice President of Sales & Marketing | 61 | |
| Ms. Sumita Nikhil Verma B.Sc. | Institutional Manager | 52 | |
| Roli Mishra M.Sc. | Manager | 45 |
Profitability and management effectiveness
Profit margin
15.88%
Operating margin
6.30%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Brooks Laboratories Limited is 1.93B and its enterprise value is 1.94B. The enterprise value to revenue ratio of BROOKS is 2.33. The enterprise value to EBITDA ratio of BROOKS is 32.42.
The BROOKS's stocks Beta value is 1.08 making it 8% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Brooks Laboratories Limited (NSE:BROOKS) Frequently Asked Questions
1. What is Brooks Laboratories Limited's Stock Symbol?
Brooks Laboratories Limited trades on NSE under the ticker symbol "BROOKS".
2. What is Brooks Laboratories Limited's stock price today?
One share of BROOKS stock can currently be purchased for approximately ₹65.5.
3. How can I contact Brooks Laboratories Limited?
Brooks Laboratories Limited's mailing address is 201, The Summit Business Park Behind Guru Nanak Petrol Pump Off. Andheri Kurla Road Andheri (East) Mumbai 400093 India. The company can be reached via phone at 91 22 6907 3100.
4. What is Brooks Laboratories Limited's official website?
The official website of Brooks Laboratories Limited is https://www.brookslabs.net.